Description

Glutoxim solution for injections 3% 2 ml. ampoules №5

Ingredients

Glutoxim solution for injections contains 3% of the active ingredient along with other excipients.

Dosage

The recommended dosage of Glutoxim solution for injections is determined by a healthcare professional based on the individual’s condition. It is typically administered via intramuscular or intravenous injection.

Indications

Glutoxim solution for injections is indicated for the treatment of various conditions where its immunomodulatory effects are beneficial.

Contraindications

Do not use Glutoxim solution for injections if you are allergic to any of the ingredients or if you have certain medical conditions. Consult with a healthcare provider for guidance.

Directions

Follow the instructions provided by your healthcare provider for the proper administration of Glutoxim solution for injections. Do not self-administer without medical supervision.

Scientific Evidence

Studies have shown that Glutoxim, the active ingredient in Glutoxim solution for injections, exhibits immunomodulatory properties that can help in the management of certain conditions. Research published in the Journal of Immunology demonstrated the efficacy of Glutoxim in modulating immune responses, highlighting its potential therapeutic benefits.

Additional Information

It is important to store Glutoxim solution for injections as per the instructions to maintain its stability and effectiveness. Always check the expiry date before use and discard any expired product. If you experience any adverse reactions, discontinue use and seek medical attention.

Pharmacological Effects: Glutoxim acts by stimulating the immune system, enhancing the body’s defense mechanisms against various pathogens and abnormal cells. This mechanism of action makes it a valuable agent in conditions where immune modulation is required.

Clinical Trials: Clinical trials evaluating the efficacy of Glutoxim have shown promising results in improving immune function and reducing symptoms in patients with immune-related disorders. Further research is ongoing to explore its potential in other therapeutic areas.